Co-Authors
This is a "connection" page, showing publications co-authored by Katherine Kedzierska and Patrick Reading.
Connection Strength
0.117
-
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2021 10; 21(10):1383-1394.
Score: 0.059
-
Influenza, but not SARS-CoV-2, infection induces a rapid interferon response that wanes with age and diminished tissue-resident memory CD8+ T cells. Clin Transl Immunology. 2021; 10(1):e1242.
Score: 0.058